These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3023331)

  • 1. Synergistic inhibition of glucagon-induced effects on hepatic glucose metabolism in the presence of insulin and a cAMP antagonist.
    Marks JS; Botelho LH
    J Biol Chem; 1986 Dec; 261(34):15895-9. PubMed ID: 3023331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the specific cAMP antagonist, (Rp)-adenosine cyclic 3',5'-phosphorothioate, on the cAMP-dependent protein kinase-induced activity of hepatic glycogen phosphorylase and glycogen synthase.
    Rothermel JD; Perillo NL; Marks JS; Botelho LH
    J Biol Chem; 1984 Dec; 259(24):15294-300. PubMed ID: 6096366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of hepatic glycogenolysis in the presence of insulin and a cAMP antagonist.
    Marks JS; Botelho LH
    J Biol Chem; 1986 Feb; 261(6):2781-5. PubMed ID: 3005264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatic gluconeogenesis by the Rp-diastereomer of adenosine cyclic 3',5'-phosphorothioate.
    Dragland-Meserve CJ; Olivieri MC; Botelho LH
    Biochem J; 1986 Jul; 237(2):463-8. PubMed ID: 3026318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glucagon-induced glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3',5'-phosphorothioate.
    Rothermel JD; Jastorff B; Botelho LH
    J Biol Chem; 1984 Jul; 259(13):8151-5. PubMed ID: 6330102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the mechanism of glucagon-induced protein phosphorylation in isolated rat hepatocytes using (Sp)-cAMPS and (Rp)-cAMPS, the stimulatory and inhibitory diastereomers of adenosine cyclic 3',5'-phosphorothioate.
    Connelly PA; Botelho LH; Sisk RB; Garrison JC
    J Biol Chem; 1987 Mar; 262(9):4324-32. PubMed ID: 3031072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3',5'-phosphorothioate.
    Rothermel JD; Stec WJ; Baraniak J; Jastorff B; Botelho LH
    J Biol Chem; 1983 Oct; 258(20):12125-8. PubMed ID: 6313639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of hepatic ketogenesis in the presence of insulin and a cAMP antagonist.
    Olivieri MC; Botelho LH
    Biochem Biophys Res Commun; 1989 Mar; 159(2):741-7. PubMed ID: 2539126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclic AMP-dependent protein kinase-induced changes in the kinetic properties of hepatic pyruvate kinase by the specific cyclic AMP antagonist, the (Rp)-diastereomer of adenosine cyclic 3',5'-phosphorothioate.
    Dragland-Meserve CJ; Rothermel JD; Houlihan MJ; Botelho LH
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):371-82. PubMed ID: 2993387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the alpha-adrenergic activation of hepatic glucose output. I. Studies on the alpha-adrenergic activation of phosphorylase and gluconeogenesis and inactivation of glycogen synthase in isolated rat liver parenchymal cells.
    Hutson NJ; Brumley FT; Assimacopoulos FD; Harper SC; Exton JH
    J Biol Chem; 1976 Sep; 251(17):5200-8. PubMed ID: 8456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the cyclic AMP antagonist, Rp-cAMPS, to distinguish between cyclic AMP-dependent and cyclic AMP-independent contractile responses in rat ventricular cardiomyocytes.
    Bell D; McDermott BJ
    J Mol Cell Cardiol; 1994 Nov; 26(11):1439-48. PubMed ID: 7897668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adrenalectomy on hormone action on hepatic glucose metabolism. Impaired glucagon activation of glycogen phosphorylase in hepatocytes from adrenalectomized rats.
    Chan TM; Steiner KE; Exton JH
    J Biol Chem; 1979 Nov; 254(22):11374-8. PubMed ID: 227869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of protein kinase and glycogen phosphorylase in isolated rat liver cells by glucagon and catecholamines.
    Birnbaum MJ; Fain JN
    J Biol Chem; 1977 Jan; 252(2):528-35. PubMed ID: 188818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of hepatic glycogen metabolism in the rhesus monkey: effect of glucose, insulin, and glucagon administration.
    Curnow RT; Rayfield EJ; George DT; Zenser TV; De Rubertis F
    Am J Physiol; 1975 Jan; 228(1):80-7. PubMed ID: 167592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal regulation of glycogen metabolism in human fetal liver. I. Normal development and effects of dibutyryl cyclic AMP, glucagon, and insulin in liver explants.
    Schwartz AL; Raiha NC; Rall TW
    Diabetes; 1975 Dec; 24(12):1101-12. PubMed ID: 172397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered mechanism of glucagon-mediated hepatic glycogenolysis during long-term starvation in the rat.
    Goldstein DE; Sutherland CA; Curnow RT
    Metabolism; 1978 Oct; 27(10):1491-8. PubMed ID: 211368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rp-cAMPS Prodrugs Reveal the cAMP Dependence of First-Phase Glucose-Stimulated Insulin Secretion.
    Schwede F; Chepurny OG; Kaufholz M; Bertinetti D; Leech CA; Cabrera O; Zhu Y; Mei F; Cheng X; Manning Fox JE; MacDonald PE; Genieser HG; Herberg FW; Holz GG
    Mol Endocrinol; 2015 Jul; 29(7):988-1005. PubMed ID: 26061564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of reduced ATP concent on hepatic responses to glucagon.
    DeRubertis FR; Craven P
    Metabolism; 1976 Jan; 25(1):57-67. PubMed ID: 173976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic AMP-dependent and cyclic AMP-independent antagonism of insulin activation of cardiac glycogen synthase.
    Ramachandran C; Angelos KL; Walsh DA
    J Biol Chem; 1982 Feb; 257(3):1448-57. PubMed ID: 6276386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the hepatic calcium-mobilizing activity of aluminum fluoride and glucagon. Modulation by cAMP and phorbol myristate acetate.
    Blackmore PF; Exton JH
    J Biol Chem; 1986 Aug; 261(24):11056-63. PubMed ID: 2426266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.